post-authorisation safety study
as defined in Directive 2001/83/EC of the European Parliament and of the Council of 6…, Article 1, point (15)
A pharmacoepidemiological study or a clinical trial carried out in accordance with the terms of the marketing authorisation, conducted with the aim of identifying or quantifying a safety hazard relating to an authorised medicinal product.